NDC 59651-367 – Vigabatrin
Vigabatrin 500 mg/1 · Tablet · Oral
Product NDC59651-367
Product details
- Brand name
- Vigabatrin
- Generic name
- Vigabatrin
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA215601
- Marketed since
- May 10, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Anti-epileptic Agent
Active ingredients
- Vigabatrin 500 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 59651-367-01 | 1 BOTTLE in 1 CARTON (59651-367-01) / 100 TABLET in 1 BOTTLE | May 10, 2022 |
Other Vigabatrin products
- 0591-3851 Vigabatrin 500 mg/1 · Tablet, Film Coated · Actavis Pharma, Inc.
- 69238-1425 Vigabatrin 500 mg/1 · For Solution · Amneal Pharmaceuticals NY LLC
- 69238-1424 Vigabatrin 500 mg/1 · Tablet · Amneal Pharmaceuticals NY LLC
- 60219-1425 Vigabatrin 500 mg/1 · For Solution · Amneal Pharmaceuticals NY LLC
- 67877-674 Vigabatrin 50 mg/mL · Powder, For Solution · Ascend Laboratories, LLC
- 59651-366 Vigabatrin 500 mg/1 · Powder, For Solution · Aurobindo Pharma Limited
- 80005-167 Vigabatrin 500 mg/1 · Tablet, Film Coated · Carnegie Pharmaceuticals LLC
- 69097-964 Vigabatrin 500 mg/mL · Powder, For Solution · Cipla USA, Inc.
- 43598-697 Vigabatrin 50 mg/mL · Powder, For Solution · Dr. Reddys Laboratories Inc.,
- 43598-651 Vigabatrin 500 mg/1 · Tablet, Film Coated · Dr. Reddys Laboratories Inc.,
- 42799-950 Vigabatrin 500 mg/1 · Tablet · Edenbridge Pharmaceuticals LLC.
- 0054-0652 Vigabatrin 500 mg/1 · Tablet · Hikma Pharmaceuticals USA Inc